Diclofenac sodium gel in patients with primary hand osteoarthritis: A randomized, double-blind, placebo-controlled trial

Journal of Rheumatology

Volumn 36, Issue 9, 2009, Pages 1991-1999

  Altman, Roy D ^a,g   Dreiser, Renée Liliane ^b   Fisher, Chester L ^c   Chase, Walter F ^d   Dreher, Donatus S ^e   Zacher, Josef ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BICHAT HOSPITAL   (France)

^c Health Research of Hampton Roads   (United States)

^d Capital Medical Clinic   (United States)

^e Novartis Consumer Health Inc   (Switzerland)

^f HELIOS KLINIKUM BERLIN BUCH   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diclofenac sodium; Nonsteroidal antiinflammatory agents; Osteoarthritis; Pain; Topical administration

Indexed keywords

DICLOFENAC; PLACEBO;

ADULT; AGED; APPLICATION SITE DERMATITIS; APPLICATION SITE PARESTHESIA; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GEL; HAND; HEADACHE; HEART DISEASE; HUMAN; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; NECK PAIN; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SKIN ALLERGY; SORE THROAT; TONGUE EDEMA; TOPICAL TREATMENT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VISUAL ANALOG SCALE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; GELS; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70349254797     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081316     Document Type: Article

References (41)

1. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006;20:3-25.
2. Buckwalter JA, Martin JA. Osteoarthritis. Adv Drug Deliv Rev 2006;58:150-167
3. Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, Pols HA, Hazes JM, Koes BW. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam Study). Ann Rheum Dis 2005;64:682-687 (Pubitemid 40559292)
4. Haara MM, Manninen P, Kröger H, et al. Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis 2003;62:151-158 (Pubitemid 36135391)
5. van Saase JLCM, van Romunde LKJ, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-280
6. Wilder FV, Barrett JP, Farina EJ. Joint-specific prevalence of osteoarthritis of the hand. Osteoarthritis Cartilage 2006;14:953-957
7. Chaisson CE, Zhang Y, McAlindon TE, et al. Radiographic hand osteoarthritis: incidence, patterns, and influence of pre-existing disease in a population based sample. J Rheumatol 1997;24:1337-1343 (Pubitemid 27353378)
8. Aspelund G, Gunnarsdóttir S, Jónsson P, Jónsson H. Hand osteoarthritis in the elderly. Application of clinical criteria. Scand J Rheumatol 1996;25:34-36 (Pubitemid 126425947)
9. Mannoni A, Briganti MP, Di Bari M, et al. Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis 2003;62:576-578
10. Mannoni A, Briganti MP, Di Bari M, et al. Prevalence of symptomatic hand osteoarthritis in community-dwelling older persons: the ICARe Dicomano study. Insufficienza Cardiaca negli Anzizni Residenti a Dicomano. Osteoarthritis Cartilage 2000;8 Suppl:S11-S3.
11. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. Am J Epidemiol 2002;156:1021-1027
12. Jones G, Cooley HM, Bellamy N. A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain. Osteoarthritis Cartilage 2001;9:606-611 (Pubitemid 32998380)
13. Kjeken I, Dagfinrud H, Slatkowsky-Christensen B, et al. Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning. Ann Rheum Dis 2005;64:1633-1638 (Pubitemid 41532049)
14. Hochberg MC, Dougados M. Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol 2001;15:583-593
15. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-796
16. Harris RC. COX-2 and the kidney. J Cardiovasc Pharmacol 2006;47 Suppl 1:S37-42.
17. Hermann M, Ruschitzka F. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Ann Med 2007;39:18-27. (Pubitemid 46272629)
18. Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol 1991;31:588-598
19. White WB. Cardiovascular risk, hypertension, and NSAIDs. Curr Rheumatol Rep 2007;9:36-43.
20. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 2004;5:28. (Pubitemid 40217428)
21. Altman R, Brandt K, Hochberg M, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4:217-243 (Pubitemid 26408292)
22. Maheu E, Altman RD, Bloch DA, et al. Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthritis Cartilage 2006;14:303-322 (Pubitemid 44268927)
23. Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33:1601-1610
24. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
25. Bellamy N, Campbell J, Haraoui B, et al. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthritis Cartilage 2002;10:855-862 (Pubitemid 35378771)
26. Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12:389-399 (Pubitemid 38594267)
27. Grifka JK, Zacher J, Brown JP, et al. Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand. Clin Exp Rheumatol 2004;22:589-596 (Pubitemid 39302936)
28. Zacher J, Burger K, Farber L, et al. Topical diclofenac Emulgel versus oral ibuprofen in the treatment of active osteoarthritis of the finger joints (Heberden's and/or Bouchard's nodes). Double-blind, controlled, randomized study. Aktuel Rheumatology 2001;26:7-14.
29. Bennell KL, Hinman RS, Metcalf BR, et al. Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial. Ann Rheum Dis 2005;64:906-912 (Pubitemid 40733917)
30. Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29-33. (Pubitemid 40075270)
31. Riess W, Schmid K, Botta L, et al. The percutaneous absorption of diclofenac. Arzneimittelforschung 1986;36:1092-1096
32. Muller M, Rastelli C, Ferri P, Jansen B, Breiteneder H, Eichler HG. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998;25:1833-1836 (Pubitemid 28439281)
33. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-388 (Pubitemid 46579641)
34. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-162 (Pubitemid 351222155)
35. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329:324. (Pubitemid 39062301)
36. Mejjad O, Maheu E. Therapeutic trials in hand osteoarthritis: a critical review. Osteoarthritis Cartilage 2000;8 Suppl:S57-63.
37. Towheed TE. Systematic review of therapies for osteoarthritis of the hand. Osteoarthritis Cartilage 2005;13:455-462 (Pubitemid 40716469)
38. Widrig R, Suter A, Saller R, Melzer J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study. Rheumatol Int 2007;27:585-591 (Pubitemid 46411900)
39. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004;31:2002-2012
40. Bookman AAM, Williams KSA, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. Can Med Assoc J 2004;171:333-338
41. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 2004;164:2017-2023 (Pubitemid 39390559)